Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.
Also called NCT07607275
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT07607275
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07607275. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-15 (actual); primary completion 2027-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
- Condition
- Hypertension
- Condition
- Essential (Primary) Hypertension
- Intervention (Drug)
- Yufeng Ningxin tablets
- Intervention (Drug)
- Placebo
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct07607275- Content hash
9f2ca033942f83073ff7fea54aaa08632ba0884b08773eeee7b0969ee8d82759